Target intelligence / Profile preview

Off-target mRNAs with partial complementarity to CD44 shRNA guide strand

Molecular classification
Messenger RNA
01

Overview

Off-target mRNAs with partial complementarity to CD44 shRNA guide strand refers to a diverse set of messenger RNAs that are inadvertently silenced during RNA interference (RNAi) experiments targeting the CD44 gene. This phenomenon occurs when the guide strand of a short hairpin RNA (shRNA) shares sequence similarity, particularly in the 6-8 nucleotide seed region, with unintended transcripts (Jackson, A. L., et al., 2003) [1]. Upon binding, the RNA-induced silencing complex (RISC) can trigger the degradation or translational repression of these off-target mRNAs, leading to a signature of unintended gene silencing (Birmingham, A., et al., 2006) [2]. Such effects are a significant concern in functional genomics as they can produce false-positive phenotypes that are incorrectly attributed to the loss of CD44 (Sigoillot, F. D., et al., 2012) [3]. In a therapeutic context, these off-target interactions represent a major safety hurdle, potentially causing systemic toxicity or disrupting essential cellular pathways (Fedorov, Y., et al., 2006) [4]. Consequently, rigorous validation using multiple shRNA sequences or rescue experiments is required to distinguish true biological effects from these artifacts.

Other names
RNAi off-target effectsSeed-mediated off-targetsUnintended gene silencingshRNA off-target transcripts
02

Mechanism of action

Seed-mediated mRNA degradation and translational inhibition via the RNA-induced silencing complex (RISC)

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Cellular toxicityFalse positive experimental resultsUnintended gene silencingConfounding phenotypic changes
06

Interacting drugs

CD44 shRNA
07

Biomarkers

RNA-seqMicroarray analysisQuantitative PCR (qPCR)

Beyond the preview

Go deeper on Off-target mRNAs with partial complementarity to CD44 shRNA guide strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target mRNAs with partial complementarity to CD44 shRNA guide strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call